SCHEMBL29428187

SCHEMBL29428187

CCC(CC)(Oc1cc2c(Nc3cccc(OC)c3)ncnc2cc1OC)C(N)=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 8/20 0.69
▸ SRC P12931 5/20 0.69
▸ RET P07949 3/20 0.69
▸ FLT4 P35916 3/20 0.61
▸ PDGFRB P09619 2/20 0.61
▸ EPHB2 P29323 2/20 0.57
▸ FLT1 P17948 2/20 0.57
▸ FGFR1 P11362 1/20 0.57
▸ CDK2 P24941 1/20 0.57
▸ PIK3R1 P27986 1/20 0.57
▸ KIF5B P33176 1/20 0.57
▸ TTBK1 Q5TCY1 1/20 0.57
▸ LRRK2 Q5S007 2/20 0.56
▸ NOD1 Q9Y239 1/20 0.56
▸ EGFR P00533 7/20 0.55
▸ MAPK14 Q16539 3/20 0.55
▸ KDM4E B2RXH2 2/20 0.54
▸ ABL1 P00519 2/20 0.54
▸ CYP1A2 P05177 2/20 0.54
▸ CYP3A4 P08684 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28438498 1.00 KDR (0.69) KDRSRCRETFLT4PDGFRB
SCHEMBL29428175 0.91 KDR (0.67) KDRRETEPHB2EGFRMAPK14
SCHEMBL28443058 0.91 KDR (0.67) KDRRETEPHB2EGFRMAPK14
SCHEMBL28444272 0.90 EGFR (0.67) KDRRETEPHB2EGFRABCG2
SCHEMBL29428181 0.90 EGFR (0.67) KDRRETEPHB2EGFRABCG2
SCHEMBL28897563 0.88 KDR (0.73) KDRSRCRETFLT4PDGFRB
SCHEMBL29428177 0.86 KDR (0.63) KDRRETEGFRABCG2GAK
SCHEMBL28441304 0.86 KDR (0.63) KDRRETEGFRABCG2GAK
SCHEMBL5474772 0.83 KDR (1.00) KDRSRCRETEPHB2FLT1
Hydrochloric Acid SCHEMBL5483854 0.82 KDR (0.97) KDRSRCRETEPHB2FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111499583-B Quinazoline derivative and application thereof as antitumor drug 沈阳工业大学 2022-02-15 — — CN disclosed
Send feedback